Company intelligence / Profile preview
Amphastar Pharmaceuticals
Rancho Cucamonga, California, United Statesamphastar.com ↗
- Ownership
- Public · AMPH
- Employees
- ~1615
- Development stage
- Commercial
01
Overview
Amphastar Pharmaceuticals is a publicly traded company with a robust portfolio of injectable, intranasal, and inhalation products. It has received several FDA approvals for its products, including generic versions of complex drugs.
- Therapeutic areas
- EndocrinologyCardiovascularNeurologyPulmonology
- Modalities
- Injectableintranasalinhalation productsbiologicsbiosimilarscomplex medications
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
03
Partnerships
Eli Lilly (acquired Baqsimi)
04
Financials
- Market cap
- $1.2B
- Total revenue
- $719.9M
- Enterprise value
- $1B
Beyond the preview
Go deeper on Amphastar Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Amphastar Pharmaceuticals.